Flow Cytometry Market Size, Share, Growth Analysis, By Technology (Cell-Based, Bead-Based), Product & Service (Instruments, Software), Application (Research, Immunology), By Region - Industry Forecast 2024-2031

North America led the market with a 41.20% revenue share in 2023, driven by a robust healthcare system and pharmaceutical sector in the U.S., generating high demand for flow cytometry in clinical and research applications. Extensive R&D in therapeutics and increased public-private investments in cancer research have further boosted the need for these instruments. For instance, in December 2023, AlleSense was commissioned to advance cancer diagnostics using cutting-edge technologies, with an initial investment of around USD 2.5 million, significantly contributing to market growth.

The Asia-Pacific flow cytometry market is expected to grow significantly from 2024 to 2030 due to the expanding pharmaceutical and biotechnology sectors in emerging economies like China and India. Market growth is driven by the rising prevalence of chronic diseases and increased use of cytometry devices in various applications. Additionally, continuous innovations in cancer and infectious disease research are projected to significantly contribute to regional market growth. Extensive research activities by regional players aiming to develop innovative flow cytometry solutions are also expected to bolster market expansion in Asia-Pacific during the forecast period.